Respiratory Research (Nov 2018)

Heterogeneous burden of lung disease in smokers with borderline airflow obstruction

  • Cheryl S. Pirozzi,
  • Tian Gu,
  • Pedro M. Quibrera,
  • Elizabeth E. Carretta,
  • MeiLan K. Han,
  • Susan Murray,
  • Christopher B. Cooper,
  • Donald P. Tashkin,
  • Eric C. Kleerup,
  • Igor Barjaktarevic,
  • Eric A. Hoffman,
  • Carlos H. Martinez,
  • Stephanie A. Christenson,
  • Nadia N. Hansel,
  • R. Graham Barr,
  • Eugene R. Bleecker,
  • Victor E. Ortega,
  • Fernando J. Martinez,
  • Richard E. Kanner,
  • Robert Paine,
  • for the NHLBI SubPopulations and InteRmediate Outcome Measures In COPD Study (SPIROMICS)

DOI
https://doi.org/10.1186/s12931-018-0911-z
Journal volume & issue
Vol. 19, no. 1
pp. 1 – 10

Abstract

Read online

Abstract Background The identification of smoking-related lung disease in current and former smokers with normal FEV1 is complex, leading to debate regarding using a ratio of forced expiratory volume in 1 s to forced vital capacity (FEV1/FVC) of less than 0.70 versus the predicted lower limit of normal (LLN) for diagnosis of airflow obstruction. We hypothesized that the discordant group of ever-smokers with FEV1/FVC between the LLN and 0.70 is heterogeneous, and aimed to characterize the burden of smoking-related lung disease in this group. Methods We compared spirometry, chest CT characteristics, and symptoms between 161 ever-smokers in the discordant group and 940 ever-smokers and 190 never-smokers with normal FEV1 and FEV1/FVC > 0.70 in the SPIROMICS cohort. We also estimated sensitivity and specificity for diagnosing objective radiographic evidence of chronic obstructive pulmonary disease (COPD) using different FEV1/FVC criteria thresholds. Results The discordant group had more CT defined emphysema and non-emphysematous gas trapping, lower post-bronchodilator FEV1 and FEF25–75, and higher respiratory medication use compared with the other two groups. Within the discordant group, 44% had radiographic CT evidence of either emphysema or non-emphysematous gas trapping; an FEV1/FVC threshold of 0.70 has greater sensitivity but lower specificity compared with LLN for identifying individuals with CT abnormality. Conclusions Ever-smokers with normal FEV1 and FEV1/FVC LLN are a heterogeneous group that includes significant numbers of individuals with and without radiographic evidence of smoking-related lung disease. These findings emphasize the limitations of diagnosing COPD based on spirometric criteria alone.

Keywords